<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE eSummaryResult PUBLIC "-//NLM//DTD esummary medgen 20130524//EN" "http://eutils.ncbi.nlm.nih.gov/eutils/dtd/20130524/esummary_medgen.dtd">
<eSummaryResult>
<DocumentSummarySet status="OK">
<DbBuild>Build141124-1357.1</DbBuild>

<DocumentSummary uid="336867">
	<ConceptId>C1845167</ConceptId>
	<Title>Dent disease 2</Title>
	<Definition>Dent disease, an X-linked disorder of proximal renal tubular dysfunction, is characterized by low molecular-weight (LMW) proteinuria, hypercalciuria, nephrocalcinosis, nephrolithiasis, and chronic kidney disease (CKD). Males younger than age ten years may manifest only low molecular-weight (LMW) proteinuria and/or hypercalciuria, which are usually asymptomatic. Thirty to 80% of affected males develop end-stage renal disease (ESRD) between ages 30 and 50 years; in some instances ESRD does not develop until the sixth decade of life or later. Rickets or osteomalacia are occasionally observed, and mild short stature, although underappreciated, may be a common occurrence. Disease severity can vary within the same family. Males with Dent disease 2 (caused by mutation of OCRL) are at increased risk for intellectual disability. Due to random X-chromosome inactivation, some female carriers may manifest hypercalciuria and, rarely, renal calculi and moderate LMW proteinuria. Females rarely if ever develop CKD.</Definition>
	<SemanticId>T047</SemanticId>
	<SemanticType>Disease or Syndrome</SemanticType>
	<Suppressed></Suppressed>
	<ConceptMeta>&lt;Names&gt;&lt;Name SDUI=&quot;300555&quot; CODE=&quot;300555&quot; SAB=&quot;OMIM&quot; TTY=&quot;PT&quot; type=&quot;syn&quot;&gt;DENT DISEASE 2&lt;/Name&gt;&lt;Name SDUI=&quot;C564487&quot; SCUI=&quot;M0564787&quot; CODE=&quot;C564487&quot; SAB=&quot;MSH&quot; TTY=&quot;NM&quot; type=&quot;syn&quot;&gt;Dent Disease 2&lt;/Name&gt;&lt;Name SDUI=&quot;GTRT000001952&quot; CODE=&quot;AN0084357&quot; SAB=&quot;GTR&quot; TTY=&quot;PT&quot; type=&quot;preferred&quot;&gt;Dent disease 2&lt;/Name&gt;&lt;Name SDUI=&quot;GTRT000001952&quot; CODE=&quot;AN0348120&quot; SAB=&quot;GTR&quot; TTY=&quot;SYN&quot; type=&quot;syn&quot;&gt;Dent Disease Type II&lt;/Name&gt;&lt;Name SDUI=&quot;Orphanet_93623&quot; CODE=&quot;AN0449423&quot; SAB=&quot;ORDO&quot; TTY=&quot;PT&quot; type=&quot;syn&quot;&gt;Dent disease type 2&lt;/Name&gt;&lt;Name SDUI=&quot;Orphanet_93623&quot; CODE=&quot;AN0470672&quot; SAB=&quot;ORDO&quot; TTY=&quot;SYN&quot; type=&quot;syn&quot;&gt;Nephrolithiasis type 2&lt;/Name&gt;&lt;/Names&gt;&lt;Definitions&gt;&lt;Definition source=&quot;GeneReviews&quot;&gt;Dent disease, an X-linked disorder of proximal renal tubular dysfunction, is characterized by low molecular-weight (LMW) proteinuria, hypercalciuria, nephrocalcinosis, nephrolithiasis, and chronic kidney disease (CKD). Males younger than age ten years may manifest only low molecular-weight (LMW) proteinuria and/or hypercalciuria, which are usually asymptomatic. Thirty to 80% of affected males develop end-stage renal disease (ESRD) between ages 30 and 50 years; in some instances ESRD does not develop until the sixth decade of life or later. Rickets or osteomalacia are occasionally observed, and mild short stature, although underappreciated, may be a common occurrence. Disease severity can vary within the same family. Males with Dent disease 2 (caused by mutation of OCRL) are at increased risk for intellectual disability. Due to random X-chromosome inactivation, some female carriers may manifest hypercalciuria and, rarely, renal calculi and moderate LMW proteinuria. Females rarely if ever develop CKD.&lt;/Definition&gt;&lt;/Definitions&gt;&lt;Chromosome&gt;X&lt;/Chromosome&gt;&lt;Cytogenetic&gt;Xq26.1&lt;/Cytogenetic&gt;&lt;ModesOfInheritance&gt;&lt;ModeOfInheritance uid=&quot;425042&quot; CUI=&quot;CN001297&quot; TUI=&quot;T045&quot;&gt;&lt;Name&gt;X-linked recessive inheritance&lt;/Name&gt;&lt;SemanticType&gt;Genetic Function&lt;/SemanticType&gt;&lt;Definition&gt;A mode of inheritance that is observed for recessive traits related to a gene encoded on the X chromosome. In the context of medical genetics, X-linked recessive disorders manifest in males (who have one copy of the X chromosome and are thus hemizygotes), but generally not in female heterozygotes who have one mutant and one normal allele.&lt;/Definition&gt;&lt;/ModeOfInheritance&gt;&lt;/ModesOfInheritance&gt;&lt;PharmacologicResponse&gt;&lt;/PharmacologicResponse&gt;&lt;PharmacologicResponse&gt;&lt;/PharmacologicResponse&gt;&lt;OMIM&gt;&lt;MIM&gt;300555&lt;/MIM&gt;&lt;/OMIM&gt;&lt;ClinicalFeatures&gt;&lt;ClinicalFeature uid=&quot;9232&quot; CUI=&quot;C0019322&quot; TUI=&quot;T190&quot; SDUI=&quot;HP:0001537&quot;&gt;&lt;Name&gt;Umbilical hernia&lt;/Name&gt;&lt;SemanticType&gt;Anatomical Abnormality&lt;/SemanticType&gt;&lt;/ClinicalFeature&gt;&lt;ClinicalFeature uid=&quot;87607&quot; CUI=&quot;C0349588&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0004322&quot;&gt;&lt;Name&gt;Short stature&lt;/Name&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;/ClinicalFeature&gt;&lt;ClinicalFeature uid=&quot;333360&quot; CUI=&quot;C1839606&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0003126&quot;&gt;&lt;Name&gt;Low-molecular-weight proteinuria&lt;/Name&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;/ClinicalFeature&gt;&lt;ClinicalFeature uid=&quot;383844&quot; CUI=&quot;C1856145&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0100543&quot;&gt;&lt;Name&gt;Cognitive impairment&lt;/Name&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;/ClinicalFeature&gt;&lt;ClinicalFeature uid=&quot;349145&quot; CUI=&quot;C1859342&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0000114&quot;&gt;&lt;Name&gt;Proximal tubulopathy&lt;/Name&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;/ClinicalFeature&gt;&lt;ClinicalFeature uid=&quot;504348&quot; CUI=&quot;CN000117&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0000121&quot;&gt;&lt;Name&gt;Nephrocalcinosis&lt;/Name&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;Definition&gt;Nephrocalcinosis is the deposition of calcium salts in renal parenchyma.&lt;/Definition&gt;&lt;/ClinicalFeature&gt;&lt;ClinicalFeature uid=&quot;504774&quot; CUI=&quot;CN001157&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0001263&quot;&gt;&lt;Name&gt;Global developmental delay&lt;/Name&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;Definition&gt;A delay in the achievement of motor or mental milestones in the domains of development of a child, including motor skills, speech and language, cognitive skills, and social and emotional skills. This term should only be used to describe children younger than five years of age.&lt;/Definition&gt;&lt;/ClinicalFeature&gt;&lt;ClinicalFeature uid=&quot;505127&quot; CUI=&quot;CN001948&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0002150&quot;&gt;&lt;Name&gt;Hypercalciuria&lt;/Name&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;/ClinicalFeature&gt;&lt;ClinicalFeature uid=&quot;505493&quot; CUI=&quot;CN002923&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0003236&quot;&gt;&lt;Name&gt;Elevated serum creatine phosphokinase&lt;/Name&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;Definition&gt;An elevation of the level of the enzyme creatine kinase (also known as creatine phosphokinase, CPK; EC 2.7.3.2) in the blood. CPK levels can be elevated in a number of clinical disorders such as myocardial infarction, rhabdomyolysis, and muscular dystrophy.&lt;/Definition&gt;&lt;/ClinicalFeature&gt;&lt;ClinicalFeature uid=&quot;425142&quot; CUI=&quot;CN003029&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0003355&quot;&gt;&lt;Name&gt;Aminoaciduria&lt;/Name&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;Definition&gt;An increased concentration of an amino acid in the urine.&lt;/Definition&gt;&lt;/ClinicalFeature&gt;&lt;ClinicalFeature uid=&quot;776439&quot; CUI=&quot;CN183891&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0012622&quot;&gt;&lt;Name&gt;Chronic kidney disease&lt;/Name&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;Definition&gt;Functional anomaly of the kidney persisting for at least three months.&lt;/Definition&gt;&lt;/ClinicalFeature&gt;&lt;/ClinicalFeatures&gt;&lt;PhenotypicAbnormalities&gt;&lt;Category CUI=&quot;CN000115&quot; name=&quot;Abnormality of the genitourinary system&quot;&gt;&lt;ClinicalFeature uid=&quot;504348&quot; CUI=&quot;CN000117&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0000121&quot;&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;Name&gt;Nephrocalcinosis&lt;/Name&gt;&lt;Definition&gt;Nephrocalcinosis is the deposition of calcium salts in renal parenchyma.&lt;/Definition&gt;&lt;/ClinicalFeature&gt;&lt;ClinicalFeature uid=&quot;425142&quot; CUI=&quot;CN003029&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0003355&quot;&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;Name&gt;Aminoaciduria&lt;/Name&gt;&lt;Definition&gt;An increased concentration of an amino acid in the urine.&lt;/Definition&gt;&lt;/ClinicalFeature&gt;&lt;ClinicalFeature uid=&quot;776439&quot; CUI=&quot;CN183891&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0012622&quot;&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;Name&gt;Chronic kidney disease&lt;/Name&gt;&lt;Definition&gt;Functional anomaly of the kidney persisting for at least three months.&lt;/Definition&gt;&lt;/ClinicalFeature&gt;&lt;/Category&gt;&lt;Category CUI=&quot;CN000664&quot; name=&quot;Abnormality of the nervous system&quot;&gt;&lt;ClinicalFeature uid=&quot;504774&quot; CUI=&quot;CN001157&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0001263&quot;&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;Name&gt;Global developmental delay&lt;/Name&gt;&lt;Definition&gt;A delay in the achievement of motor or mental milestones in the domains of development of a child, including motor skills, speech and language, cognitive skills, and social and emotional skills. This term should only be used to describe children younger than five years of age.&lt;/Definition&gt;&lt;/ClinicalFeature&gt;&lt;/Category&gt;&lt;Category CUI=&quot;CN001754&quot; name=&quot;Abnormality of metabolism/homeostasis&quot;&gt;&lt;ClinicalFeature uid=&quot;505493&quot; CUI=&quot;CN002923&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0003236&quot;&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;Name&gt;Elevated serum creatine phosphokinase&lt;/Name&gt;&lt;Definition&gt;An elevation of the level of the enzyme creatine kinase (also known as creatine phosphokinase, CPK; EC 2.7.3.2) in the blood. CPK levels can be elevated in a number of clinical disorders such as myocardial infarction, rhabdomyolysis, and muscular dystrophy.&lt;/Definition&gt;&lt;/ClinicalFeature&gt;&lt;ClinicalFeature uid=&quot;425142&quot; CUI=&quot;CN003029&quot; TUI=&quot;T033&quot; SDUI=&quot;HP:0003355&quot;&gt;&lt;SemanticType&gt;Finding&lt;/SemanticType&gt;&lt;Name&gt;Aminoaciduria&lt;/Name&gt;&lt;Definition&gt;An increased concentration of an amino acid in the urine.&lt;/Definition&gt;&lt;/ClinicalFeature&gt;&lt;/Category&gt;&lt;/PhenotypicAbnormalities&gt;&lt;RelatedDisorders&gt;&lt;/RelatedDisorders&gt;&lt;SNOMEDCT&gt;&lt;/SNOMEDCT&gt;&lt;AssociatedGenes&gt;&lt;Gene gene_id=&quot;4952&quot; chromosome=&quot;X&quot; cytogen_loc=&quot;Xq26.1&quot;&gt;OCRL&lt;/Gene&gt;&lt;/AssociatedGenes&gt;</ConceptMeta>
	<ModificationDate></ModificationDate>
	<Merged></Merged>
</DocumentSummary>

</DocumentSummarySet>
</eSummaryResult>
